Hypoxic regulation of vascular endothelial growth factor in retinal cells

L. P. Aiello, J. M. Northrup, B. A. Keyt, H. Takagi and M. A. Iwamoto
Research Division, Joslin Diabetes Center, Boston, Mass., USA.

BACKGROUND: Vascular endothelial growth factor (VEGF) is an angiogenic protein and vasopermeability factor whose intraocular concentrations are closely correlated with active neovascularization in patients with diabetes mellitus, central retinal vein occlusion, retinopathy of prematurity, and rubeosis iridis. OBJECTIVE: To determine whether hypoxia could induce expression of VEGF in retinal cells, which then promotes retinal endothelial cell proliferation. METHODS: Retinal pigment epithelial cells, pericytes, and microvascular endothelial cells were exposed to hypoxic conditions in vitro, and RNA expression of VEGF was evaluated by Northern blot analysis. The VEGF-specific proliferative potential of the medium was measured by means of retinal endothelial cell growth assays and VEGF-neutralizing VEGF receptor IgG chimeric protein. RESULTS: The VEGF RNA levels increased within 4 hours and reached elevations of threefold to 30-fold after 18 hours of hypoxia (0% to 5% oxygen, 5% carbon dioxide, 90% to 95% nitrogen) in all cell types (.01 < P < .03). Stimulation was dependent on oxygen concentration. The VEGF RNA levels were normalized by reinstitution of normoxia for 24 hours (P < .004). Medium conditioned by hypoxic retinal pericytes and retinal pigment epithelial cells stimulated retinal endothelial cell growth by 20% (P = .04), and this stimulation was entirely inhibited by VEGF-neutralizing receptor chimeric protein (P = .02). CONCLUSION: Hypoxia increases VEGF expression in retinal cells, which promotes retinal endothelial cell proliferation, suggesting that VEGF plays a major role in mediating intraocular neovascularization resulting from ischemic retinal diseases.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Racial Differences and Other Risk Factors for Incidence and Progression of Age-Related Macular Degeneration: Salisbury Eye Evaluation (SEE) Project
Chang et al.
IOVS 2008;49:2395-2402.
ABSTRACT | FULL TEXT  

Early Effects of Triamcinolone on Vascular Endothelial Growth Factor and Endostatin in Human Choroidal Neovascularization
Tatar et al.
Arch Ophthalmol 2008;126:193-199.
ABSTRACT | FULL TEXT  

Positive Feedback Regulation between MMP-9 and VEGF in Human RPE Cells
Hollborn et al.
IOVS 2007;48:4360-4367.
ABSTRACT | FULL TEXT  

Multiple Variants in Vascular Endothelial Growth Factor (VEGFA) Are Risk Factors for Time to Severe Retinopathy in Type 1 Diabetes: The DCCT/EDIC Genetics Study
Al-Kateb et al.
Diabetes 2007;56:2161-2168.
ABSTRACT | FULL TEXT  

A chronic grey matter penumbra, lateral microvascular intussusception and venous peduncular avulsion underlie diabetic vitreous haemorrhage
McLeod
Br. J. Ophthalmol. 2007;91:677-689.
ABSTRACT | FULL TEXT  

Specific Involvement of Src Family Kinase Activation in the Pathogenesis of Retinal Neovascularization
Werdich and Penn
IOVS 2006;47:5047-5056.
ABSTRACT | FULL TEXT  

Anti-VEGF Aptamer (Pegaptanib) Therapy for Ocular Vascular Diseases
NG and ADAMIS
Ann. N. Y. Acad. Sci. 2006;1082:151-171.
ABSTRACT | FULL TEXT  

Single Periocular Injection of Celecoxib-PLGA Microparticles Inhibits Diabetes-Induced Elevations in Retinal PGE2, VEGF, and Vascular Leakage.
Amrite et al.
IOVS 2006;47:1149-1160.
ABSTRACT | FULL TEXT  

Inhibition of NAD(P)H Oxidase Activity Blocks Vascular Endothelial Growth Factor Overexpression and Neovascularization during Ischemic Retinopathy
Al-Shabrawey et al.
Am. J. Pathol. 2005;167:599-607.
ABSTRACT | FULL TEXT  

The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment
Mohan et al.
Br. J. Ophthalmol. 2005;89:815-819.
ABSTRACT | FULL TEXT  

Near Confluent Laser Photocoagulation for the Treatment of Threshold Retinopathy of Prematurity
Rezai et al.
Arch Ophthalmol 2005;123:621-626.
ABSTRACT | FULL TEXT  

Preclinical Pharmacokinetics of Ranibizumab (rhuFabV2) after a Single Intravitreal Administration
Gaudreault et al.
IOVS 2005;46:726-733.
ABSTRACT | FULL TEXT  

Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes
Nagaoka et al.
Br. J. Ophthalmol. 2004;88:1060-1063.
ABSTRACT | FULL TEXT  

Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants
Mamputu and Renier
J. Leukoc. Biol. 2004;75:1062-1069.
ABSTRACT | FULL TEXT  

Homocysteine Increases the Expression of Vascular Endothelial Growth Factor by a Mechanism Involving Endoplasmic Reticulum Stress and Transcription Factor ATF4
Roybal et al.
J. Biol. Chem. 2004;279:14844-14852.
ABSTRACT | FULL TEXT  

Diabetic Retinopathy
Frank
NEJM 2004;350:48-58.
FULL TEXT  

Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research
Donnelly et al.
Br. J. Ophthalmol. 2004;88:145-151.
ABSTRACT | FULL TEXT  

Experimental Diabetes Causes Breakdown of the Blood-Retina Barrier by a Mechanism Involving Tyrosine Nitration and Increases in Expression of Vascular Endothelial Growth Factor and Urokinase Plasminogen Activator Receptor
El-Remessy et al.
Am. J. Pathol. 2003;162:1995-2004.
ABSTRACT | FULL TEXT  

Enhanced Recombinant Adeno-Associated Virus-Mediated Vascular Endothelial Growth Factor Expression in the Adult Mouse Retina: A Potential Model for Diabetic Retinopathy
Rakoczy et al.
Diabetes 2003;52:857-863.
ABSTRACT | FULL TEXT  

Rapid Insulin-Like Growth Factor (IGF)-Independent Effects of IGF Binding Protein-3 on Endothelial Cell Survival
Franklin et al.
J. Clin. Endocrinol. Metab. 2003;88:900-907.
ABSTRACT | FULL TEXT  

Pigment Epithelium-Derived Factor Suppresses Ischemia-Induced Retinal Neovascularization and VEGF-Induced Migration and Growth
Duh et al.
IOVS 2002;43:821-829.
ABSTRACT | FULL TEXT  

Differential Effects of Bactericidal/Permeability-Increasing Protein (BPI) Analogues on Retinal Neovascularization and Retinal Pericyte Growth
Rauniyar et al.
IOVS 2002;43:503-509.
ABSTRACT | FULL TEXT  

c-Abl Is Required for the Development of Hyperoxia-induced Retinopathy
Nunes et al.
J. Exp. Med. 2001;193:1383-1392.
ABSTRACT | FULL TEXT  

Response of Experimental Retinal Neovascularization to Thiazolidinediones
Murata et al.
Arch Ophthalmol 2001;119:709-717.
ABSTRACT | FULL TEXT  

Vitreous Levels of Vascular Cell Adhesion Molecule and Vascular Endothelial Growth Factor in Patients With Proliferative Diabetic Retinopathy: A case-control study
Hernández et al.
Diabetes Care 2001;24:516-521.
ABSTRACT | FULL TEXT  

Cyclic Stretch and Hypertension Induce Retinal Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor--2: Potential Mechanisms for Exacerbation of Diabetic Retinopathy by Hypertension
Suzuma et al.
Diabetes 2001;50:444-454.
ABSTRACT | FULL TEXT  

Bilateral Iris Neovascularization as the Initial Sign of Obesity-Hypoventilation (Pickwickian) Syndrome: Hypoxia/Hypercapnia as a Stimulus for Angiogenesis
Duh et al.
Arch Ophthalmol 2000;118:1298-1300.
FULL TEXT  

Pentoxifylline Inhibition of Vasculogenesis in the Neonatal Rat Retina
Hasebe et al.
IOVS 2000;41:2774-2778.
ABSTRACT | FULL TEXT  

Choroidal neovascularisation at a demarcation line: an immunopathological study
PARMAR et al.
Br. J. Ophthalmol. 2000;84:928a-928.
FULL TEXT  

Plasma VEGF and Soluble VEGF Receptor FLT-1 in Proliferative Retinopathy: Relationship to Endothelial Dysfunction and Laser Treatment
Lip et al.
IOVS 2000;41:2115-2119.
ABSTRACT | FULL TEXT  

Mechanisms of Hepatocyte Growth Factor-Induced Retinal Endothelial Cell Migration and Growth
Cai et al.
IOVS 2000;41:1885-1893.
ABSTRACT | FULL TEXT  

Quantitative MR Imaging Study of Intravitreal Sustained Release of VEGF in Rabbits
Alikacem et al.
IOVS 2000;41:1561-1569.
ABSTRACT | FULL TEXT  

Vascular Endothelial Growth Factor and Hepatocyte Growth Factor Levels Are Differentially Elevated in Patients with Advanced Retinopathy of Prematurity
Lashkari et al.
Am. J. Pathol. 2000;156:1337-1344.
ABSTRACT | FULL TEXT  

Multifocal Electroretinogram Delays Reveal Local Retinal Dysfunction in Early Diabetic Retinopathy
Fortune et al.
IOVS 1999;40:2638-2651.
ABSTRACT | FULL TEXT  

The Potential Angiogenic Role of Macrophages in the Formation of Choroidal Neovascular Membranes
Oh et al.
IOVS 1999;40:1891-1898.
ABSTRACT | FULL TEXT  

Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus
Shinoda et al.
Br. J. Ophthalmol. 1999;83:834-837.
ABSTRACT | FULL TEXT  

Angiogenic factors in human proliferative sickle cell retinopathy
Cao et al.
Br. J. Ophthalmol. 1999;83:838-846.
ABSTRACT | FULL TEXT  

Transcription Factors Sp1 and Sp3 Alter Vascular Endothelial Growth Factor Receptor Expression through a Novel Recognition Sequence
Hata et al.
J. Biol. Chem. 1998;273:19294-19303.
ABSTRACT | FULL TEXT  

Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy
Chantelau
Br. J. Ophthalmol. 1998;82:725-730.
ABSTRACT | FULL TEXT  

Vascular Endothelial Growth Factor mRNA in Pericytes Is Upregulated by Phorbol Myristate Acetate
Kim et al.
Hypertension 1998;31:511-515.
ABSTRACT | FULL TEXT  

Role of vascular permeability factor/vascular endothelial growth factor in eye disease
SCHLINGEMANN and VAN HINSBERGH
Br. J. Ophthalmol. 1997;81:501-512.
FULL TEXT  

Increased expression of angiogenic growth factors in age-related maculopathy
Kliffen et al.
Br. J. Ophthalmol. 1997;81:154-162.
ABSTRACT | FULL TEXT  

Stretch-induced Retinal Vascular Endothelial Growth Factor Expression Is Mediated by Phosphatidylinositol 3-Kinase and Protein Kinase C (PKC)-zeta but Not by Stretch-induced ERK1/2, Akt, Ras, or Classical/Novel PKC Pathways
Suzuma et al.
J. Biol. Chem. 2002;277:1047-1057.
ABSTRACT | FULL TEXT